Effects of dual antiplatelet therapy de-escalation on the prognosis of acute coronary syndrome patients at high risk of ischemia who underwent percutaneous coronary intervention

被引：0
|
作者：
Wang, Jingyao [1 ]
Li, Yachao [1 ]
Lei, Mengjie [1 ]
Yang, Yanli [1 ]
Gao, Haiyan [1 ]
Wang, Xiangjin [1 ]
An, Lei [1 ]
Zhou, Haili [1 ]
Sun, Xue [1 ]
Li, Cairong [1 ]
Zhao, Zhigang [1 ]
Xue, Zengming [1 ]
机构：
[1] Hebei Med Univ, Langfang Peoples Hosp, Dept Cardiol, Langfang Core Lab Precis Treatment Coronary Artery, 37 Xinhua Rd, Langfang 065000, Hebei, Peoples R China
来源：
CHINESE MEDICAL JOURNAL | 2024年 / 137卷 / 06期
关键词：
ACUTE MYOCARDIAL-INFARCTION; CLOPIDOGREL; TICAGRELOR;
D O I：
10.1097/CM9.0000000000003011
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：746 / 748
页数：3
相关论文
共 50 条
  • [41] De-escalation of anti-platelet therapy in patients with acute coronary syndromes undergoing percutaneous coronary intervention: a narrative review
    Han, Ya-Ling
    CHINESE MEDICAL JOURNAL, 2019, 132 (02) : 197 - 210
  • [42] De-Escalation of Antiplatelet Therapy in Patients With Coronary Artery Disease Undergoing Percutaneous Coronary Intervention: A Meta-Analysis of Randomized Clinical Trials
    Kheiri, Babikir
    Osman, Mohammed
    Abdalla, Ahmed
    Ahmed, Sahar
    Osman, Khansa
    Bachuwa, Ghassan
    Hassan, Mustafa
    Bhatt, Deepak L.
    CIRCULATION, 2018, 138
  • [43] Short dual antiplatelet therapy and dual antiplatelet therapy de-escalation after primary percutaneous intervention: For whom and how
    Muthspiel, Marie
    Kaufmann, Christoph C. C.
    Burger, Achim Leo
    Panzer, Benjamin
    Verheugt, Freek W. A.
    Huber, Kurt
    FRONTIERS IN CARDIOVASCULAR MEDICINE, 2022, 9
  • [44] De-escalation of antiplatelet treatment after percutaneous coronary interventions for acute coronary syndromes: is less more?
    Varenne, Olivier
    Sinnaeve, Peter R.
    EUROPEAN HEART JOURNAL, 2018, 39 (29) : 2759 - 2761
  • [45] Escalation and De-Escalation of Antiplatelet Therapy after Acute Coronary Syndrome or PCI: Available Evidence and Implications for Practice
    Gragnano, Felice
    Capolongo, Antonio
    Terracciano, Fabrizia
    Gargiulo, Giuseppe
    De Sio, Vincenzo
    Cesaro, Arturo
    Moscarella, Elisabetta
    Patti, Giuseppe
    Porto, Italo
    Esposito, Giovanni
    Angiolillo, Dominick J.
    Calabro, Paolo
    JOURNAL OF CLINICAL MEDICINE, 2022, 11 (21)
  • [46] De-escalation of antiplatelet therapy in acute coronary syndromes: Why, how and when?
    Galli, Mattia
    Angiolillo, Dominick J.
    FRONTIERS IN CARDIOVASCULAR MEDICINE, 2022, 9
  • [47] Meta-analysis of duration of dual antiplatelet therapy in patients with acute coronary syndrome after percutaneous coronary intervention
    Khan, Safi U.
    Bin Riaz, Irbaz
    Rahman, Hammad
    Lone, Ahmed N.
    Raza, Munis
    Khan, Muhammad Shahzeb
    Riaz, Anum
    Kaluski, Edo
    EUROPEAN JOURNAL OF PREVENTIVE CARDIOLOGY, 2019, 26 (04) : 429 - 432
  • [48] Outpatient Trends in Dual Antiplatelet Therapy Following Acute Coronary Syndrome and Primary Percutaneous Coronary Intervention
    Buchanan, Kyle D.
    Alraies, M. Chadi
    Rogers, Toby
    Steinvil, Arie
    Gai, Jiaxiang
    Torguson, Rebecca
    Koifman, Edward
    Ben-Dor, Itsik
    Pichard, Augusto D.
    Satler, Lowell
    Waksman, Ron
    JACC-CARDIOVASCULAR INTERVENTIONS, 2017, 10 (03) : S14 - S14
  • [49] Dual antiplatelet therapy after acute coronary syndrome or percutaneous coronary intervention: with what and for how long?
    Darius, Harald
    INTERNIST, 2021, 62 (11): : 1243 - 1252
  • [50] OUTPATIENT TRENDS IN DUAL ANTIPLATELET THERAPY FOLLOWING ACUTE CORONARY SYNDROME AND PRIMARY PERCUTANEOUS CORONARY INTERVENTION
    Waksman, Ron
    Buchanan, Kyle
    Alraies, M. Chadi
    Rogers, Toby
    Steinvil, Arie
    Koifman, Edward
    Torguson, Rebecca
    Gai, Jiaxiang
    Ben-Dor, Itsik
    Pichard, Augusto
    Satler, Lowell
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2017, 69 (11) : 1019 - 1019
12345